London, United Kingdom--(Newsfile Corp. - November 12, 2024) - Akanda Corp . (NASDAQ: AKAN) (the "Company" or "Akanda"), today announced that it expects to implement a 1-for-2 reverse stock split of the Company's common shares effective November 14, 2024. The reverse stock split was previously approved by the Company's shareholders on March 22, 2024 and Board of Directors on October 25, 2024 and will begin trading on an... Read More

London, United Kingdom--(Newsfile Corp. - October 4, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, entered into an underwriting agreement (the "Underwriting Agreement") with Univest Securities, LLC ("Univest") as the underwriter in connection with the issuance and sale by the Company in an underwritten public offering (the "Offering") of 258,940 of the Company's... Read More

London, United Kingdom--(Newsfile Corp. - October 2, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has entered into a firm commitment underwriting agreement with Univest Securities, LLC, as underwriter, whereby Univest has agreed to purchase 1,500,000 common shares (or pre-funded warrants in lieu thereof) at a public offering price of $1.00... Read More

London, United Kingdom--(Newsfile Corp. - September 16, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), a global cannabis company, is excited to announce that it has obtained a license for hemp cultivation in Canada. This license is directly tied to Akanda's previously announced agreement with 1107385 B.C. LTD, further advancing the company's strategic initiatives in the Canadian cannabis market. This latest... Read More

London, United Kingdom--(Newsfile Corp. - June 14, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has successfully completed sales of its securities under its existing Form F-3 shelf registration. The shelf registration statement had a $5 million capacity and allowed the Company to raise cash by selling stock and warrants into the open... Read More

London, United Kingdom--(Newsfile Corp. - June 12, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has received a letter (the "Compliance Notice") from the Listing Qualifications Department of The Nasdaq Stock Market Inc. ("Nasdaq") dated June 7, 2024, informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2)... Read More

London, United Kingdom--(Newsfile Corp. - May 21, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, reported that it expects to implement a 1-for-40 reverse stock split on its ordinary shares effective May 23, 2024, with trading to begin on a split-adjusted basis at the market open on that day. Trading in the ordinary shares will continue on The Nasdaq Capital Market... Read More

London, United Kingdom--(Newsfile Corp. - May 20, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has closed its previously announced second registered direct offering for the sale and issuance of 2,491,381common shares at a purchase price of $0.1031 and 12,057,600 pre-funded warrants to purchase 12,057,600 common shares at $0.103 per share,... Read More

London, United Kingdom--(Newsfile Corp. - May 17, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has entered into a second securities purchase agreement with an accredited investor whereby the investor has agreed to purchase 2,491,381common shares at a purchase price of $0.1031 and 12,057,600 pre-funded warrants to purchase 12,057,600 common... Read More

London, United Kingdom--(Newsfile Corp. - May 17, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has closed its previously announced registered direct offering for the sale and issuance of 2,491,381 common shares at a purchase price of $0.1031 per share, and 21,756,922 pre-funded warrants to purchase 21,756,922 common shares at a price of... Read More

London, United Kingdom--(Newsfile Corp. - May 17, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has entered into a securities purchase agreement with an accredited investor whereby the investor has agreed to purchase 2,491,381 common shares at a purchase price of $0.1031 and 21,756,922 pre-funded warrants to purchase 21,756,922 common... Read More

London, United Kingdom--(Newsfile Corp. - May 16, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), announced that it has received a deficiency notification letter from the Nasdaq Listing Qualifications Department on May 14, 2024, due to non-compliance with the minimum stockholders' equity requirement as set forth in Nasdaq Listing Rule 5550(b)(1). According to Nasdaq's listing requirements, companies must... Read More

London, United Kingdom--(Newsfile Corp. - May 13, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), today announced a settlement agreement with former chief executive officer and director, Tejinder Virk, concluding a series of disputes that commenced following Mr. Virk's resignation on February 3, 2023. The settlement resolves all outstanding claims and disputes Mr. Virk had with the Company and its... Read More

London, United Kingdom--(Newsfile Corp. - May 10, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announces it is actively following the landmark change in federal US policy to reschedule cannabis under the Controlled Substances Act ("CSA"). It has been widely reported that as of April 30, 2024 the DEA plans to reclassify cannabis as a Schedule III substance.... Read More

London, United Kingdom--(Newsfile Corp. - April 25, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, Akanda Corp. announces the appointment of Christopher Cooper to its board of directors following the resignation of Harvinder Singh as a director. Mr. Christopher Cooper has over 20 years of extensive business experience in all facets of corporate development, senior... Read More

London, United Kingdom--(Newsfile Corp. - April 15, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, previously announced the completion of several public offerings and the sale of its indirectly wholly-owned Portuguese subsidiary, RPK BioPharma Unipessoal, LDA ("RPK") now announces its plans to pause any potential equity financings for a thirty (30) day period while... Read More

London, United Kingdom--(Newsfile Corp. - April 12, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, announces its plans to enter the blockchain and artificial intelligence sector of the cannabis industry. With an increasingly complex and global supply chain for the international cannabis industry, the Company believes companies and consumers will turn to blockchain... Read More

London, United Kingdom--(Newsfile Corp. - April 12, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, Akanda Corp. announces its plans to evaluate and pursue strategic investments in the expanded legalized German market. On April 1, 2024, Germany became the third European Union country to legalize cannabis for personal use after Malta and Luxembourg. The new law... Read More

London, United Kingdom--(Newsfile Corp. - April 11, 2024) - On April 4, 2024, Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, announced its wholly-owned United Kingdom (UK) subsidiary, Canmart, plans to develop its social shopping capability by integrating with META, to create a user friendly buying experience for Facebook and Instagram users to purchase Canmart products.... Read More

London, United Kingdom--(Newsfile Corp. - April 11, 2024) - On April 1, 2024, Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, completed the transaction with SOMAÍ Pharmaceuticals Ltd. (the "Buyer") for the sale of RPK, its indirect wholly-owned Portuguese subsidiary. Pursuant to the provisions set forth in the definitive share purchase agreement, the cash purchase price is... Read More

London, United Kingdom--(Newsfile Corp. - March 28, 2024) - Akanda Corp. ("Akanda" or the "Company") (NASDAQ: AKAN), an international medical cannabis company, Akanda Corp. announced its wholly-owned United Kingdom (UK) subsidiary, Canmart, plans to develop its social shopping capability by integrating with META, to create a user friendly buying experience for Facebook and Instagram users to purchase Canmart products. In... Read More

London, United Kingdom--(Newsfile Corp. - March 28, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, announced aspirations to enter technology segments of the cannabis industry. The Company is evaluating potential opportunities to enter Bitcoin, Blockchain, and AI applications in the cannabis industry. The Company believes cryptocurrencies may provide a viable... Read More

London, United Kingdom--(Newsfile Corp. - March 27, 2024) - On March 24, 2024, Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, entered into an underwriting agreement (the "Underwriting Agreement") with Univest Securities, LLC ("Univest") as the underwriter in connection with the issuance and sale by the Company in an underwritten public offering (the "Offering") of... Read More

New York, March 27, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of underwritten public offering (the “Offering”) of 3,087,443 common stock priced at $0.1217 per share, with pre-funded warrants exercisable for 37,997,190 shares with respect to the underwritten public... Read More

London, United Kingdom--(Newsfile Corp. - March 25, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has entered into a firm commitment underwriting agreement with Univest Securities, LLC, as underwriter, whereby Univest has agreed to purchase up to 41,084,634 common shares or pre-funded warrants at a public offering price of $0.1217 per share... Read More

London, United Kingdom--(Newsfile Corp. - February 29, 2024) - Akanda Corp. (NASDAQ: AKAN) (" Akanda " or the " Company "), an international medical cannabis company, today announced the signing of a definitive Share Purchase Agreement and Escrow Agreement with Somai Pharmaceuticals Unipessoal, LDA ("Somai"), marking a significant milestone in the sale of its Portuguese subsidiary, RPK BioPharma Unipessoal, LDA ("RPK"). This... Read More

London, United Kingdom--(Newsfile Corp. - February 20, 2024) - Akanda Corp. (NASDAQ: AKAN) (" Akanda " or the " Company "), an international medical cannabis company, today announces that it has received an order from the Ontario Superior Court of Justice (the " Court ") permitting Akanda to hold its annual meeting of shareholders (the " Meeting ") on or before March 23, 2024, pursuant to an application to the Court... Read More

London, United Kingdom--(Newsfile Corp. - February 20, 2024) - Akanda Corp. (NASDAQ: AKAN) (" Akanda " or the " Company "), an international medical cannabis company, today announces that it has made an application to the Ontario Superior Court of Justice (the " Court ") to extend the deadline for it to hold its annual meeting of shareholders (the " Meeting ") from February 22, 2024 to March 23, 2024. Under Ontario law, the... Read More

London, United Kingdom--(Newsfile Corp. - February 13, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), provides an overview of the growing cannabis market in the United Kingdom and promising trends among patients. 2023 was a dynamic year for the UK cannabis market. Patients grew and so did imports. November of 2023 marked five years since the UK government legalized cannabis-based products for medicinal use... Read More

London, United Kingdom--(Newsfile Corp. - February 2, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has closed its previously announced registered direct offering for the sale and issuance of 280,851 common shares at a purchase price of $0.406 per share, and pre-funded warrants to purchase 1,462,991 common shares at a price of $0.4059 per... Read More

London, United Kingdom--(Newsfile Corp. - February 2, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announces it is actively following the developments in federal US policy to reschedule and/or deschedule cannabis under the Controlled Substances Act ("CSA"). The Company believes rescheduling may reinvigorate capital markets and could lead to changes in... Read More

London, United Kingdom--(Newsfile Corp. - February 2, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has entered into a securities purchase agreement with certain accredited investors whereby the investors have agreed to purchase 280,851 common shares at a purchase price of $0.406 per share and pre-funded warrants to purchase 1,462,991... Read More

London, United Kingdom--(Newsfile Corp. - February 1, 2024) - Akanda Corp . (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announces it has entered into an Amended Non-Binding Letter of Intent ("LOI")with Somai Pharmaceuticals Ltd. for the sale of RPK, its Portuguese subsidiary. Pursuant to the provisions set forth in the LOI, the duration of said LOI has been extended through... Read More

London, United Kingdom--(Newsfile Corp. - January 4, 2024) - International medical cannabis platform company Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") an Ontario company, announced today it received an extension of 180 calendar days from The Nasdaq Stock Market LLC ("Nasdaq") to regain compliance with the Nasdaq's minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued... Read More

London, United Kingdom--(Newsfile Corp. - December 11, 2023) - International medical cannabis platform company Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") an Ontario company, reported that it has appointed a new Chief Financial Officer. Effective immediately Charn Deol will join the Company and come to Akanda with more than 35 years of financial markets. The Board replaced on December 4 th 2023, the current CFO... Read More

FRANKFURT, Germany & LONDON / Sep 20, 2023 / Business Wire / International medical cannabis company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN, WKN: A3DG83) announces that Akanda (the “Optionee” the “Company”) and 1107385 B.C. LTD (the “ Owner ”) have agreed upon terms to purchase farming land and related operations and licenses. The key deal terms are as follows: Akanda will issue a non-refundable payment equal... Read More

LONDON / Jul 06, 2023 / Business Wire / International medical cannabis platform company Akanda Corp. ("Akanda" or the “Company”) (NASDAQ: AKAN) today announced that the Company has received a written notification (the “Notification Letter”) on July 3, 2023 from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is not in compliance with the minimum bid price... Read More

FRANKFURT, Germany & LONDON / May 29, 2023 / Business Wire / International Medical Cannabis Company, Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN, WKN: A3DG83) announces that Akanda and Veridia Canada Ltd. (the “Lender”) have mutually agreed to terminate the loan agreement between the parties previously announced on April 18, 2023 (the “Loan Agreement”). Akanda has returned all funds provided under the terms of the... Read More

FRANKFURT, Germany & LONDON / Apr 28, 2023 / Business Wire / International medical cannabis company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN, WKN: A3DG83) announces that it has entered into a loan agreement dated April 26, 2023 (the “Loan Agreement”) with Veridia Canada Ltd. (the “Lender”), in the principal amount of €500,000 (approximately C$738,650) (the “Loan”), which has been advanced in full by the Lender.... Read More

LONDON / Mar 29, 2023 / Business Wire / International medical cannabis platform company Akanda Corp. ("Akanda" or the “Company”) (NASDAQ: AKAN) an Ontario company, today announced that it received a notification letter (the “Notification Letter on Compliance”) from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (the “Nasdaq”) dated March 27, 2023, indicating that the Company has regained compliance... Read More

International medical cannabis platform company Akanda Corp. ("Akanda" or the “Company”) (NASDAQ: AKAN) an Ontario company, reported that it expects to implement a 1-for-10 reverse stock split on its ordinary shares effective Thursday March 9, with trading to begin on a split-adjusted basis at the market open on that day. Trading in the ordinary shares will continue on the Nasdaq Capital Market under the symbol “AKAN”. The... Read More

International medical cannabis platform company Akanda Corp. ("Akanda" or the “Company”) (NASDAQ: AKAN) an Ontario company, reported that it has appointed a new Chief Financial Officer. Effective immediately Shailesh Bhushan will join the company, and comes to Akanda with more than 25 years of financial and accounting experience. “I am pleased to welcome Shailesh to the Akanda executive management team,” said Katharyn Field,... Read More

International medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced its subsidiary Canmart Ltd. brought Tejinder Virk’s Service Agreement dated June 2, 2021 (the “Service Agreement”) to an immediate end with effect from February 13 th , 2023. As disclosed on February 7 th , 2023, the Company disclosed Mr. Virk’s attempt to end the Service Agreement without providing the... Read More

International medical cannabis platform company Akanda Corp . ("Akanda" or the “Company”) (NASDAQ: AKAN) today announced that Tejinder Virk resigned from his position as CEO and Director of the Company. Mr. Virk notified the Company of his resignation on February 3, 2023. Mr. Virk’s resignation was a result of disagreement with the company regarding contractual obligations owed pursuant to the Service Agreement dated June 2,... Read More

International medical cannabis company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN, WKN: A3DG83) today announced that it successfully launched its initial supply to German customers recognizing approximately €1,803,996M 1 in sales of EU GMP high-quality indoor-grown medical cannabis in the last quarter of 2022. On a preliminary, unaudited basis, Akanda has recognized its first material revenues since its... Read More

International medical cannabis platform company Akanda Corp. ("Akanda" or the “Company”) (NASDAQ: AKAN) today announced that Chief Executive Officer Tej Virk has been on a paid leave of absence both administrative and personal since November 30, 2022, pending an independent investigation being conducted by Canmart Directors and counsel. During his leave, Mr. Virk is not expected to perform any responsibilities as the Chief... Read More

Company to focus on core European operations and will exit Africa. Akanda will assert its creditor claims concerning the unauthorized liquidation of its former subsidiary in Lesotho Akanda releases new investor presentation Medical cannabis cultivation company Akanda Corp. ("Akanda" or the "Company") (NASDAQ: AKAN) (Frankfurt: Y23) is affirming a shift in strategy to become a significant player as a premium EU GMP cultivator... Read More

Akanda announces first export shipment to Germany of high THC indoor cultivated premium cannabis from its Portugal-based operation Akanda is enabling sales of medical cannabis for patients across Germany Akanda stands ready to serve legal adult-use markets in Europe once established International medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) expects to take a leading position in... Read More

International medical cannabis platform company Akanda Corp. ("Akanda" or the “Company”) (NASDAQ: AKAN) today announced that the Company has received a written notification (the “Notification Letter”) on September 27, 2022 from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is not in compliance with the minimum bid price requirement set forth under Nasdaq... Read More

International medical cannabis platform company Akanda Corp. ("Akanda" or the “Company”) (NASDAQ: AKAN) expects to take a leading position in the fast-growing German medical cannabis market, as it prepares for first export shipment from its Portugal-based Holigen operation in the coming weeks. Akanda’s EU GMP certified indoor... Read More

International medical cannabis platform company Akanda Corp. ("Akanda" or the “Company”) (NASDAQ: AKAN) today announced an exclusive license agreement with iconic international cannabis lifestyle brand Cookies. The multi-year agreement enables Akanda to pursue the current medical and future adult-use opportunities in Europe with arguably one of the best-known cannabis brands and highest quality genetics in the world. Under... Read More

International cannabis company Akanda Corp. ("Akanda" or the “Company”) (NASDAQ: AKAN) today announced that Terry Booth, the founder of Aurora Cannabis Inc. (“Aurora Cannabis”) (NASDAQ:ACB) has joined Akanda as a Chair of Akanda’s newly formed Advisory Board. Terry Booth was an original founder of Aurora Cannabis. He raised Aurora from its infancy into one of the world’s largest and fastest growing cannabis companies with a... Read More

International medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced that Chief Executive Officer Tej Virk will attend the Benzinga Cannabis Capital Conference in Chicago on September 13 and 14. Virk will speak on an expert panel with executives from other international cannabis companies and be available for 1x1 meetings with investors and media throughout the event. The... Read More

International medical cannabis platform company Akanda Corp . (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced that it has appointed Tom Flow to the role of Chief Operating Officer of Akanda and Managing Director of Holigen, and Steven George to the role of Commercial Director, effective September 1, 2022. The Company believes that these two hires will enhance its leadership direction and boost profitability across... Read More

International medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced it has signed a multi-year supply agreement with European medical cannabis leader Cansativa GmbH (“Cansativa Group” or “Cansativa”) to supply EU-GMP quality THC dried flower strains cultivated from its Portuguese operations at Holigen. This new supply agreement marks one of the largest for medical cannabis... Read More

Akanda Corp. ("Akanda") (NASDAQ: AKAN) and Cansativa GmbH (“Cansativa Group”) today jointly announced a new cooperation that will soon allow German pharmacies to provide patients with two novel cannabis cultivars. This collaboration allows the Cansativa platform to supply the German market with dried flowers from Akanda’s EU-GMP certified indoor grow facility in Sintra, Portugal. Akanda is expected to deliver at least 1,000... Read More

Akanda Corp. ("Akanda" or the “Company”) (NASDAQ: AKAN), an international medical cannabis platform company, today announced that the High Court of Lesotho (the “Lesotho Court”) has placed in liquidation the Company’s indirect, wholly-owned subsidiary, Bophelo Bio Science & Wellness (Pty) Ltd. (“Bophelo”). The action to place Bophelo in liquidation was taken by the Lesotho Court pursuant to an unauthorized application and... Read More

International medical cannabis company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced it has closed the acquisition of Holigen Limited (“Holigen”) from The Flowr Corporation (“Flowr”) (TSXV: FLWR, OTC: FLWPF), accelerating Akanda’s seed-to-patient business model in the EMEA region, improving the Company’s ability to meet growing demand for medical cannabis and positioning it for adult use markets as... Read More

International medical cannabis company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced it has entered into a definitive agreement to acquire 100% of the issued and outstanding shares of Holigen Limited (“Holigen”) from The Flowr Corporation (“Flowr”) (TSXV: FLWR, OTC: FLWPF). The proposed acquisition... Read More

Akanda Corp. ("Akanda" or the “Company”), an international medical cannabis company, today announced the completion of its initial public offering of 4,000,000 common shares at a price of $4.00 per share to the public for a total of $16,000,000 of gross proceeds to the Company (the “Offering”), prior to deducting underwriting discounts, commissions, and other Offering expenses. All of the common shares were offered by... Read More